November 25th - 27th, 2021

SESSION 1: November 25th, 2021 · 16.30H (5’)

Welcome to the Multiple Sclerosis Preceptorship & Chair

Xavier Montalban

SESSION 1: November 25th, 2021 · 16.35H (30’)

Epidemiology of Multiple Sclerosis

Susana Otero

SESSION 1: November 25th, 2021 · 17.05H (30’)

Immunopathogenesis of Multiple Sclerosis

Heinz Wiendl

SESSION 1: November 25th, 2021 · 17.35H (30’)

Genetics of Multiple Sclerosis

Manuel Comabella

SESSION 1: November 25th, 2021 · 18.15H (30’)

Pathology of Multiple Sclerosis

Simon Hametner

SESSION 1: November 25th, 2021 · 18.45H (30’)

Focus on Neuroplasticity in Multiple Sclerosis

Luca Prosperini

SESSION 1: November 25th, 2021 · 19.15H (15')

Debate and Q&A

SESSION 2: November 26th, 2021 · 15.00H - 17.30H

Formas clínicas de la Esclerosis Múltiple

Dr. Jaume Sastre-Garriga

SESSION 2: November 26th, 2021 · 16.30H (5’)

Welcome to day 2 of the Multiple Sclerosis Preceptorship & Chair

Mar Tintoré

SESSION 2: November 26th, 2021 · 16.35H (30’)

Clinical Diagnosis of Multiple Sclerosis: criteria and beyond

Mar Tintoré

SESSION 2: November 26th, 2021 · 17.05H (30’)

Differential diagnosis

Georgina Arrambide

SESSION 2: November 26th, 2021 · 17.35H (30’)

Imaging in Multiple Sclerosis and Magnetic resonance imaging (MRI)

Alex Rovira

SESSION 2: November 26th, 2021 · 18.15H (30’)

Multiple Sclerosis phenotypes

Jaume Sastre-Garriga

SESSION 2: November 26th, 2021 · 18.45H (30’)

Neuromyelitis optica and Myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD)

Álvaro Cobo-Calvo

SESSION 2: November 26th, 2021 · 19.15H (30’)

Pediatric and juvenile Multiple Sclerosis

Luciana Midaglia

SESSION 2: November 26th, 2021 · 19.45H (15’)

Debate and Q&A

SESSION 3: November 27th, 2021 · 14.30H (5’)

Welcome to day 3 of the Multiple Sclerosis Preceptorship & Chair

Alan Thompson

SESSION 3: November 27th, 2021 · 14.35H (30’)

Overview of treatments and treatment algorithms

Daniel Ontaneda

SESSION 3: November 27th, 2021 · 15.05H (30’)

Managing treatment response in Multiple Sclerosis

Jordi Río

SESSION 3: November 27th, 2021 · 15.35H (30’)

Multiple Sclerosis Rehabilitation

Alan Thompson

SESSION 3: November 27th, 2021 · 16.15H (30’)

Optical coherence tomography (OCT) to monitor Multiple Sclerosis neurodegeneration

Ángela Vidal-Jordana

SESSION 3: November 27th, 2021 · 16.45H (30’)

Monitoring Multiple Sclerosis in the twenty-first century

Ana Zabalza

SESSION 3: November 27th, 2021 · 17.15H (30’)

Multiple Sclerosis at a glance

Xavier Montalban

SESSION 3: November 27th, 2021 · 17.45H (15’)

Debate and Q&A

         

SESSION 1

Thursday, November 25th, 2021   ·   16.30H - 19.30H

Welcome to the Multiple Sclerosis Preceptorship & Chair

Xavier Montalban

Epidemiology of Multiple Sclerosis

Susana Otero

Immunopathogenesis of Multiple Sclerosis

Heinz Wiendl

Genetics of Multiple Sclerosis

Manuel Comabella

Pathology of Multiple Sclerosis

Simon Hametner

Focus on Neuroplasticity in Multiple Sclerosis

Luca Prosperini

Debate and Q&A



SESSION 2

Friday, November 26th, 2021   ·   16.30H - 20.00H

Welcome to day 2 of the Multiple Sclerosis Preceptorship & Chair

Mar Tintoré

Clinical Diagnosis of Multiple Sclerosis: criteria and beyond

Mar Tintoré

Differential diagnosis

Georgina Arrambide

Imaging in Multiple Sclerosis and Magnetic resonance imaging (MRI)

Alex Rovira

Multiple Sclerosis phenotypes

Jaume Sastre-Garriga

Neuromyelitis optica and Myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD)

Álvaro Cobo-Calvo

Pediatric and juvenile Multiple Sclerosis

Luciana Midaglia

Debate and Q&A



SESSION 3

Saturday, November 27th, 2021   ·   14.30H - 18.00H

Welcome to day 3 of the Multiple Sclerosis Preceptorship & Chair

Alan Thompson

Overview of treatments and treatment algorithms

Daniel Ontaneda

Managing treatment response in Multiple Sclerosis

Jordi Río

Multiple Sclerosis Rehabilitation

Alan Thompson

Optical coherence tomography (OCT) to monitor Multiple Sclerosis neurodegeneration

Ángela Vidal-Jordana

Monitoring Multiple Sclerosis in the twenty-first century

Ana Zabalza

Multiple Sclerosis at a glance

Xavier Montalban

Debate and Q&A



If you have any questions, feel free to contact us at formacio@cem-cat.org.


Partners